Quick Answer
Lipocine Inc. reported Stockholders Equity of $14.48 million for fiscal year 2025.
Lipocine Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $14.48M | -31.1% |
| 2024 | $21.00M | +3.1% |
| 2023 | $20.37M | -42.8% |
| 2022 | $35.63M | -21.8% |
| 2021 | $45.57M | +197.0% |
| 2020 | $15.34M | +144.0% |
| 2019 | $6.29M | -33.3% |
| 2018 | $9.43M | -50.3% |
| 2017 | $18.98M | -27.0% |
| 2016 | $26.02M | -38.0% |
| 2015 | $41.99M | +59.3% |
| 2014 | $26.36M | -41.2% |
| 2013 | $44.82M | +743.2% |
| 2012 | $5.32M | +308.4% |
| 2011 | $1.30M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.14M | -26.0% | -17.4% |
| June 30, 2025 | $17.13M | -19.2% | -10.8% |
| March 31, 2025 | $19.20M | -19.9% | -8.6% |
| December 31, 2024 | $21.00M | +3.1% | +9.8% |
| September 30, 2024 | $19.12M | -15.0% | -9.9% |
| June 30, 2024 | $21.21M | -25.7% | -11.5% |
| March 31, 2024 | $23.96M | -25.0% | +17.6% |
| December 31, 2023 | $20.37M | -42.8% | -9.4% |
- Lipocine Inc. showed a decrease of -31.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Lipocine Inc.’s stockholders equity has grown by 1012.1% (from $1.30 million to $14.48 million).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: